GeneDx Corp. (WGS)
NASDAQ: WGS
· Real-Time Price · USD
66.78
2.21 (3.42%)
At close: Jun 16, 2025, 3:59 PM
66.53
-0.37%
After-hours: Jun 16, 2025, 06:55 PM EDT
3.42% (1D)
| Bid | 65.09 |
| Market Cap | 1.91B |
| Revenue (ttm) | 330.14M |
| Net Income (ttm) | -38.58M |
| EPS (ttm) | -1.39 |
| PE Ratio (ttm) | -48.04 |
| Forward PE | 32.65 |
| Analyst | Strong Buy |
| Ask | 66.9 |
| Volume | 520,100 |
| Avg. Volume (20D) | 1,083,050 |
| Open | 64.32 |
| Previous Close | 64.57 |
| Day's Range | 63.60 - 66.88 |
| 52-Week Range | 24.91 - 117.75 |
| Beta | 2.01 |
Analyst Forecast
According to 0 analyst ratings, the average rating for WGS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-42.85%
GeneDx Holdings shares are trading lower. The comp...
Unlock content with
Pro Subscription
3 months ago
+4.93%
GeneDx Holdings shares are trading higher after the company announced an indication expansion for its industry leading genetic testing to now include cerebral palsy.
3 weeks ago · seekingalpha.com
GeneDx: Strong Fundamentals Intact As Market Misreads Test Volume DipGeneDx delivered strong Q1 2025 results, beating revenue and EPS estimates, and raised full-year guidance despite a minor sequential test volume dip. The volume decline is attributable to seasonality,...
